Analysts Set Semler Scientific Inc. (NASDAQ:SMLR) PT at $74.25

Semler Scientific Inc. (NASDAQ:SMLR) has been assigned an average rating of “Moderate Buy” from the five brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month target price among brokers that have covered the stock in the last year is $74.25.

A number of equities analysts have recently commented on the stock. Benchmark cut their target price on shares of Semler Scientific from $101.00 to $86.00 and set a “buy” rating on the stock in a research note on Tuesday, September 23rd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Semler Scientific in a report on Monday. Finally, Maxim Group reduced their price objective on Semler Scientific from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Friday, September 19th.

Semler Scientific Stock Performance

Semler Scientific stock opened at $17.93 on Wednesday. The company has a market cap of $273.97 million, a price-to-earnings ratio of 6.45 and a beta of 1.35. Semler Scientific has a 12 month low of $15.90 and a 12 month high of $72.25. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.97 and a quick ratio of 1.95. The stock’s 50-day moving average is $22.46 and its 200-day moving average is $30.02.

Semler Scientific (NASDAQ:SMLR) last posted its earnings results on Wednesday, November 12th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.14) by $1.21. The firm had revenue of $7.49 million during the quarter, compared to the consensus estimate of $7.87 million. Semler Scientific had a net margin of 130.80% and a return on equity of 34.21%.

Hedge Funds Weigh In On Semler Scientific

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Penn Capital Management Company LLC acquired a new stake in Semler Scientific in the third quarter valued at approximately $284,000. Advisory Services Network LLC grew its holdings in Semler Scientific by 42.4% during the 3rd quarter. Advisory Services Network LLC now owns 9,404 shares of the company’s stock valued at $282,000 after purchasing an additional 2,800 shares in the last quarter. Kestra Private Wealth Services LLC purchased a new stake in Semler Scientific during the 3rd quarter worth $404,000. Millennium Management LLC lifted its holdings in Semler Scientific by 151.8% in the 3rd quarter. Millennium Management LLC now owns 65,360 shares of the company’s stock worth $1,961,000 after buying an additional 39,407 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Semler Scientific by 21.9% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,586 shares of the company’s stock valued at $168,000 after buying an additional 1,004 shares during the last quarter. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc, headquartered in Princeton, New Jersey, is a medical technology company specializing in the development and commercialization of non-invasive monitoring solutions for intracranial pressure. The company’s core focus is on improving patient care in neurocritical and acute care settings by providing clinicians with advanced diagnostic tools that reduce the risks associated with invasive procedures.

The company’s flagship product, the NICO Monitor, employs proprietary acoustic monitoring technology to continuously estimate intracranial pressure and compliance at the bedside.